Skip to main content

Want a detailed portfolio tracker?

PDS Biotechnology (PDSB) P/E (2015 - 2026)

PDS Biotechnology (PDSB) P/E from Oct 1, 2015 to Jul 21, 2026. The TTM PDS Biotechnology (PDSB) P/E is -4.48. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PDS Biotechnology (PDSB)

YearP/EChange
2026-4.48+30.78%
2025-3.42-50.58%
2024-6.92+132.99%
2023-2.97-77.82%
2022-13.40+3.32%
2021-12.97+389.25%
2020-2.65+31.40%
2019-2.02-42.71%
2018-3.52-52.40%
2017-7.40-64.75%
2016-20.98N/A
2015-20.98N/A

Comparison PDS Biotechnology (PDSB) P/E with competitors

PDS Biotechnology (PDSB) P/E is -4.48.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.10%
ENLVEnlivex Ltd0.07-101.67%
FGENFibroGen Inc0.24-105.36%
CHRSCoherus Biosciences Inc0.85-118.96%
FBIOFortress Biotech Inc0.95-121.20%
ORMPOramed Pharmaceuticals Inc1.50-133.58%
AGENAgenus Inc3.01-167.24%
INVAInnoviva Inc3.15-170.47%
VXRTVaxart Inc3.55-179.31%
CRMDCorMedix Inc3.63-181.07%
CVACCureVac N.V.4.45-199.32%
GLPGGalapagos NV4.86-208.56%
SRPTSarepta Therapeutics Inc4.88-209.07%
ABEOAbeona Therapeutics Inc5.39-220.37%
ABUSArbutus Biopharma Corp5.60-225.02%
ZVRAZevra Therapeutics Inc5.89-231.53%
SPROSpero Therapeutics Inc6.23-239.15%
CGENCompugen Ltd6.31-241.06%
RIGLRigel Pharmaceuticals6.87-253.53%
SLXNSilexion Therapeutics Corp7.30-263.01%
OMEROmeros Corporation9.26-306.86%
AUPHAurinia Pharmaceuticals Inc9.58-314.14%
PLXProtalix BioTherapeutics Inc10.89-343.32%
ACADAcadia Pharmaceuticals Inc11.73-362.04%
TBPHTheravance Biopharma Inc12.26-373.96%
ADMAAdma Biologics Inc12.42-377.44%
HRMYHarmony Biosciences Holdings Inc13.82-408.77%
SABSSAB Biotherapeutics Inc14.14-415.83%
NAGENiagen Bioscience Inc14.82-431.06%
INCYIncyte Corp15.82-453.50%
REGNRegeneron Pharmaceuticals Inc15.86-454.27%
PBYIPuma Biotechnology Inc17.32-486.86%
CPRXCatalyst Pharmaceuticals Inc17.44-489.62%
EXELExelixis Inc17.54-491.83%
TGTXTG Therapeutics Inc18.97-523.74%
MDXGMimedx Group Inc20.55-559.18%
XOMAXOMA Royalty Corp22.87-611.07%
ARGXArgen X SE24.30-642.87%
CTMXCytomX Therapeutics Inc24.82-654.56%
XOMAOXOMA Royalty Corp25.34-666.26%
HALOHalozyme Therapeutics Inc25.62-672.49%
XOMAPXOMA Royalty Corp25.67-673.53%
VRTXVertex Pharmaceuticals Inc27.99-725.47%
RPRXRoyalty Pharma plc - Class A28.69-740.95%
SLNOSoleno Therapeutics Inc29.02-748.27%
ASNDAscendis Pharma A/S30.09-772.18%
LGNDLigand Pharmaceuticals Inc - Class B37.91-947.04%
APLSApellis Pharmaceuticals Inc39.02-971.83%
BMRNBiomarin Pharmaceutical Inc42.21-1043.11%
KRYSKrystal Biotech Inc45.34-1113.08%
ONCBeiGene Ltd69.54-1653.70%
PHARPharming Group N.V.75.03-1776.25%
TECHBio-Techne Corp101.96-2377.99%
VCELVericel Corp109.92-2555.90%
ALNYAlnylam Pharmaceuticals Inc117.96-2735.62%
GMABGenmab140.29-3234.43%
TLXTelix Pharmaceuticals Ltd162.15-3722.88%
CORTCorcept Therapeutics Inc212.86-4855.74%